Compare VERA & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | DEI |
|---|---|---|
| Founded | 2016 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 1.8B |
| IPO Year | 2021 | 2006 |
| Metric | VERA | DEI |
|---|---|---|
| Price | $36.74 | $12.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 8 |
| Target Price | ★ $81.30 | $12.94 |
| AVG Volume (30 Days) | 954.9K | ★ 2.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 7.06% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,003,982,000.00 |
| Revenue This Year | N/A | $1.70 |
| Revenue Next Year | $472.48 | $2.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.77 |
| 52 Week Low | $18.76 | $9.04 |
| 52 Week High | $56.05 | $16.94 |
| Indicator | VERA | DEI |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 69.16 |
| Support Level | $34.04 | $10.85 |
| Resistance Level | $42.77 | $12.40 |
| Average True Range (ATR) | 1.86 | 0.36 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 41.27 | 77.21 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments: the office segment and multifamily segment, of which Office segment derives maximum revenue.